[시장보고서]세계의 일회용 어셈블리 시장(-2029년) : 제품별(백(2D, 3D), 여과, 보틀, 믹싱, 튜브 어셈블리), 솔루션별(맞춤형, 표준), 모달리티별(mAb, 백신, CGT), 용도별(여과, 세포배양, 보관, 이송)

세계의 일회용 어셈블리 시장(-2029년) : 제품별(백(2D, 3D), 여과, 보틀, 믹싱, 튜브 어셈블리), 솔루션별(맞춤형, 표준), 모달리티별(mAb, 백신, CGT), 용도별(여과, 세포배양, 보관, 이송)

Single Use Assemblies Market by Product (Bag (2D, 3D), Filtration, Bottle, Mixing, Tubing Assemblies), Solution (Customized, Standard), Modality (mAbs, Vaccines, CGT), Application (Filtration, Cell Culture, Storage, Transfer) - Global Forecasts to 2029

상품코드 : 1642242 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2025년 01월

페이지 정보 : 영문 428 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,089,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,524,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,672,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,322,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

일회용 어셈블리 시장 규모는 2024년 26억 3,000만 달러에서 예측 기간 동안 13.2%의 CAGR로 2029년에는 48억 9,000만 달러 규모로 성장할 것으로 예상됩니다.

시장 성장의 주요 요인은 CDMO, 중소기업, 스타트업의 채용 확대, 신속한 도입과 교차 오염 위험 감소, 생물학적 제제 및 바이오시밀러 시장의 성장, 일회용 어셈블리를 통한 비용 절감 등입니다. 또한, 기술 개발 및 아웃소싱 서비스에 대한 관심도 높아지고 있습니다. 또한, 신흥국들은 큰 개발 기회를 보이고 있으며, 바이오제약 기업들의 생산능력 확대에 대한 집중은 시장을 더욱 견인할 것으로 예상됩니다.

조사 범위
조사 대상 연도	2022-2029년
기준 연도	2023년
예측 기간	2024-2029년
단위	금액(달러)
부문	제품, 솔루션, 양식, 용도, 최종사용자
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

"가방 어셈블리별로는 2D 가방 어셈블리 부문이 2023년 가장 큰 점유율을 보였습니다."

3D 백 어셈블리에 비해 2D 백 어셈블리가 3D 백 어셈블리에 비해 우월한 이유는 보다 단순한 디자인, 취급의 용이성, 소량 생산에 적합하다는 점 등에 기인합니다. 또한, 자동화 시스템에 원활하게 통합할 수 있고, 완충액, 시약 등 다양한 유체에 적합하기 때문에 제조업체에게 선호되는 선택이 되고 있습니다.

"모달리티별로는 단클론항체(mAb) 부문이 2023년 가장 큰 점유율을 차지했습니다."

단클론항체(mAb)는 바이오의약품 시장에서 가장 큰 부문 중 하나입니다. 이 부문의 큰 점유율은 낮은 자본 투자, 낮은 노동력 요구 사항, 시간이 많이 소요되는 전환 절차 및 검증의 감소로 인해 mAb 제조에서 일회용 어셈블리에 대한 수요가 증가함에 따라 이 부문의 큰 점유율을 차지하게 되었습니다.

"미국이 2023년 시장을 주도"

미국은 세계 최대의 바이오의약품 시장이자 바이오의약품 연구 및 투자의 선두주자입니다. 미국은 또한 생명과학 분야의 연구개발을 촉진하는 강력한 헬스케어 인프라를 보유하고 있습니다. 많은 바이오 제약 기업들이 존재감을 드러내고 있으며, 생명공학 산업의 연구 활동이 활발하게 이루어지고 있는 것도 미국 시장의 성장을 촉진하고 있습니다. 또한, 자금 및 보조금 형태로 정부 기관의 지원이 증가하고 있는 것도 이 시장의 성장을 촉진하고 있습니다.

세계의 일회용 어셈블리(Single Use Assembly) 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 기술·특허 동향, 법·규제 환경, 사례 분석, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 과제
고객의 사업에 영향을 미치는 동향/디스럽션
가격 분석
공급망 분석
밸류체인 분석
생태계 분석
투자와 자금 조달 시나리오
기술 분석
특허 분석
무역 분석
주요 회의와 이벤트
규제 상황
Porter's Five Forces 분석
주요 이해관계자와 구입 기준
일회용 어셈블리 시장의 AI/생성형 AI의 영향

제6장 일회용 어셈블리 시장 : 제품별

백 어셈블리
- 2D 백 어셈블리
- 3D 백 어셈블리
- 백 어셈블리(용도별)
여과 어셈블리
보틀 어셈블리
튜브 어셈블리
믹싱 어셈블리
샘플링 어셈블리
센서 어셈블리
기타

제7장 일회용 어셈블리 시장 : 솔루션별

표준 솔루션
맞춤형 솔루션

제8장 일회용 어셈블리 시장 : 모달리티별

단클론항체(mAb)
백신
치료용 단백질·펩타이드
세포 및 유전자 치료

제9장 일회용 어셈블리 시장 : 용도별

여과 및 정화
무균 이송
보관
샘플링
세포배양
배합과 완제
믹싱

제10장 일회용 어셈블리 시장 : 최종사용자별

제약·바이오의약품 기업
CRO·CMO
학술연구기관

제11장 일회용 어셈블리 시장 : 지역별

북미
- 미국
- 캐나다
유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타
아시아태평양
- 중국
- 한국
- 일본
- 인도
- 호주
- 기타
라틴아메리카
- 브라질
- 멕시코
- 기타
중동
- GCC 국가
- 기타
아프리카

제12장 경쟁 구도

개요
주요 진출 기업 전략/강점
매출 분석
시장 점유율 분석, 2023년
기업 평가 매트릭스 : 주요 기업
기업 평가 매트릭스 : 스타트업/중소기업
기업 가치 평가와 재무 지표
브랜드/제품 비교
경쟁 시나리오

제13장 기업 개요

주요 기업
- THERMO FISHER SCIENTIFIC INC.
- SARTORIUS AG
- MERCK KGAA
- DANAHER CORPORATION
- AVANTOR, INC.
- PARKER HANNIFIN CORPORATION
- SAINT-GOBAIN
- REPLIGEN CORPORATION
- CORNING INCORPORATED
- ENTEGRIS
- LONZA
- ZACROS CORPORATION
- W. L. GORE & ASSOCIATES, INC.
기타 기업
- NEWAGE INDUSTRIES
- WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
- COBETTER
- ANTYLIA SCIENTIFIC
- NUPORE FILTRATION SYSTEMS
- INTELLITECH, INC.
- MEISSNER FILTRATION PRODUCTS, INC.
- SANISURE
- SENTINEL PROCESS SYSTEMS INC.
- FLUID FLOW PRODUCTS, INC.
- DOVER CORPORATION
- KEOFITT A/S
- CELLEXUS
- FOXX LIFE SCIENCES
- TSE INDUSTRIES, INC.

제14장 부록

KSM

영문 목차

영문목차

The single-use assemblies market is expected to grow to USD 4.89 billion by 2029, up from USD 2.63 billion in 2024, at a CAGR of 13.2% between 2024 and 2029. Growth in this market is mainly driven by the growing adoption among CDMOs, SMEs & startups, rapid implementation and low risk of cross-contamination, growing biologics & biosimilar markets, and cost savings with single-use assemblies. Furthermore, there is a growing focus on technological developments and outsourcing services. Furthermore, emerging countries provide significant development opportunities, and the focus on capacity expansion by biopharmaceutical companies is expected to drive the market further.

Scope of the Report
Years Considered for the Study	2022-2029
Base Year	2023
Forecast Period	2024-2029
Units Considered	Value (USD)
Segments	Product, Solution, Modality, Application, and End User
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

"The 2D bag assemblies segment accounted for the largest share of bag assemblies segment for the single-use assemblies market in 2023."

The bag assemblies segment of the single-use assemblies market is further divided into 2D & 3D bag assemblies. In 2023, the 2D bag assemblies segment accounted for the largest share of the global single-use assemblies market by bag assemblies. The dominance of 2D bag assemblies over 3D assemblies can be attributed to their simpler design, ease of handling, and suitability for lower-volume operations. Additionally, their ability to integrate seamlessly into automated systems and compatibility with a range of fluids, such as buffers and reagents, makes them a preferred choice for manufacturers.

"The monoclonal antibodies segment accounted for the largest share of by modalities segment for the single-use assemblies market in 2023."

In 2023, the monoclonal antibodies segment accounted for the largest share of the global single-use assemblies market by modality. Monoclonal antibodies (mAbs) are one of the largest segments of the biotechnology drugs market. Factors The large share of the monoclonal antibodies (mAbs) segment can be attributed to the increasing demand for single-use assemblies in the manufacturing of mAbs due to low capital investment, low workforce requirements, and reductions in time-consuming changeover procedures and validation.

"In 2023, the US remained to dominate the single-use assemblies market."

The US dominated the North American single-use assemblies market in 2023. The US is the world's largest biopharmaceutical market and the leader in biopharmaceutical research and investment. The United States also has a strong healthcare infrastructure, which encourages research and development in the life sciences. Additionally, the significant presence of many biopharmaceutical companies and growing research activities in the biotechnology industry are propelling market growth in the US. Moreover, the growing support from government bodies in the form of funds and grants is also driving the growth of the single-use assemblies market.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other

executives from various key organizations operating in the single-use assemblies

marketplace.

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
By Region: North America - 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Thermo Fisher Scientific Inc. (US); Sartorius AG (Germany); Danaher Corporation (US); Merck KGaA (Germany); Avantor, Inc. (US); are some of the key players in the single-use assemblies market.

The study includes an in-depth competitive analysis of these key players in the single-use assemblies market, with their company profiles, recent developments, and key market strategies

Research Coverage:

This research report categorizes the single-use assemblies market by product ( bag assemblies {2D bag assemblies and 3D bag assemblies}, filtration assemblies, bottle assemblies, tubing assemblies, mixing assemblies, sampling assemblies, sensor assemblies, and other single-use assembly products), solution (standard solutions and customized solutions), modality (monoclonal antibodies, vaccines, therapeutic proteins & peptides, and cell & gene therapies), application (filtration & purification applications, aseptic transfer, storage applications, sampling applications, cell culture, formulation & fill-finish applications, and mixing), end user (pharmaceutical & biopharmaceutical companies, CROs & CMOs, and academic & research institutes), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the single-use assemblies market. A thorough analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. Also, it includes new product launches, collaborations and acquisitions, and recent developments associated with the single-use assemblies market.

Reasons to buy this report

The report will help market leaders/new entrants by providing the closest approximations of the revenue numbers for the overall single-use assemblies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (rising adoption of single-use assemblies in biopharmaceutical manufacturing, increasing focus on advantages of single-use solutions over traditional bioprocessing, booming biologics and biosimilars market, and growing advancements in single-use assembly technologies), restraints (issues related to leachables and extractables, complex and stringent regulatory landscape for single-use products, leakage and integrity issues), opportunities (high growth in emerging economies, rising focus on expanding bioprocessing capacities), and Challenges (standardization of single-use assemblies, waste generation and disposal issues, gap between demand and supply of single-use assemblies) influencing the growth of the market.
Product Development/Innovation: Detailed insights on newly launched products of the single-use assemblies market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the single-use assemblies market
Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like Thermo Fisher Scientific Inc (US), Sartorius AG (Germany), Merck KGaA (Germany), Danaher Corporation (US), Avantor, Inc. (US), Parker Hannifin Corporation (US), Saint-Gobain (France), Repligen Corporation (US), Corning Incorporated (US), Entegris (US), among others in the market.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
- 1.3.2 INCLUSIONS AND EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 MARKET ESTIMATION
- 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
- 2.2.3 TOP-DOWN APPROACH
2.3 MARKET GROWTH RATE PROJECTION
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 SINGLE-USE ASSEMBLIES MARKET OVERVIEW
4.2 NORTH AMERICA: SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION AND COUNTRY, 2023
4.3 SINGLE-USE ASSEMBLIES MARKET, BY END USER, 2024 VS. 2029
4.4 SINGLE-USE ASSEMBLIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Rising adoption of single-use systems in biopharmaceutical manufacturing
  - 5.2.1.2 Increasing focus on advantages of single-use solutions over traditional bioprocessing
  - 5.2.1.3 Booming biologics and biosimilars market
  - 5.2.1.4 Growing advancements in single-use assembly technologies
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Issues related to leachables and extractables
  - 5.2.2.2 Complex and stringent regulatory landscape for single-use products
  - 5.2.2.3 Leakage and integrity issues
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 High growth in emerging economies
  - 5.2.3.2 Rising focus on expanding bioprocessing capacities
- 5.2.4 CHALLENGES
  - 5.2.4.1 Standardization of single-use assemblies
  - 5.2.4.2 Waste generation and disposal issues
  - 5.2.4.3 Gap between demand and supply of single-use assemblies
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
- 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
5.5 SUPPLY CHAIN ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
- 5.7.1 RAW MATERIAL SUPPLIERS
- 5.7.2 PRODUCT MANUFACTURERS
- 5.7.3 END USERS
- 5.7.4 REGULATORY BODIES
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
  - 5.9.1.1 Filtration
  - 5.9.1.2 Cell culture
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
- 5.9.3 ADJACENT TECHNOLOGIES
5.10 PATENT ANALYSIS
5.11 TRADE ANALYSIS
- 5.11.1 IMPORT DATA FOR HS CODE 392390
- 5.11.2 EXPORT DATA FOR HS CODE 392390
5.12 KEY CONFERENCES AND EVENTS
5.13 REGULATORY LANDSCAPE
- 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.13.2 REGULATORY FRAMEWORK
  - 5.13.2.1 North America
    - 5.13.2.1.1 US
    - 5.13.2.1.2 Canada
  - 5.13.2.2 Europe
    - 5.13.2.2.1 Germany
    - 5.13.2.2.2 UK
  - 5.13.2.3 Asia Pacific
    - 5.13.2.3.1 Japan
    - 5.13.2.3.2 China
  - 5.13.2.4 Latin America
    - 5.13.2.4.1 Brazil
5.14 PORTER'S FIVE FORCES ANALYSIS
- 5.14.1 THREAT OF NEW ENTRANTS
- 5.14.2 THREAT OF SUBSTITUTES
- 5.14.3 BARGAINING POWER OF BUYERS
- 5.14.4 BARGAINING POWER OF SUPPLIERS
- 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.15.2 BUYING CRITERIA
5.16 IMPACT OF AI/GENERATIVE AI ON SINGLE-USE ASSEMBLIES MARKET
- 5.16.1 INTRODUCTION
- 5.16.2 MARKET POTENTIAL FOR SINGLE-USE ASSEMBLIES
- 5.16.3 AI USE CASES
- 5.16.4 KEY COMPANIES IMPLEMENTING AI
- 5.16.5 FUTURE OF GENERATIVE AI ON SINGLE-USE ASSEMBLIES ECOSYSTEM

6 SINGLE-USE ASSEMBLIES MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 BAG ASSEMBLIES
- 6.2.1 2D BAG ASSEMBLIES
  - 6.2.1.1 Growing use in buffer preparation, media storage, and harvest collection to fuel market
- 6.2.2 3D BAG ASSEMBLIES
  - 6.2.2.1 Larger volume storage and transport capabilities to speed up growth
- 6.2.3 BAG ASSEMBLIES, BY APPLICATION
6.3 FILTRATION ASSEMBLIES
- 6.3.1 RISING FOCUS ON PREVENTING LOSSES AND MAINTAINING PRODUCT QUALITY TO BOOST MARKET
6.4 BOTTLE ASSEMBLIES
- 6.4.1 REDUCED DOWNTIME AND TURNAROUND TIME TO BOOST MARKET
- 6.4.2 BOTTLE ASSEMBLIES, BY APPLICATION
6.5 TUBING ASSEMBLIES
- 6.5.1 ENHANCED RISK MANAGEMENT AND PRODUCTION TO ENCOURAGE GROWTH
6.6 MIXING ASSEMBLIES
- 6.6.1 MINIMIZED OPERATOR EXPOSURE AND REDUCED DOWNTIME FOR CLEANING TO AID GROWTH
6.7 SAMPLING ASSEMBLIES
- 6.7.1 NEED FOR QUALITY CONTROL AND PROCESS MONITORING IN BIOPROCESSING TO AUGMENT GROWTH
6.8 SENSOR ASSEMBLIES
- 6.8.1 GROWING ADOPTION OF BIOPROCESSING AUTOMATION TO DRIVE MARKET
6.9 OTHER SINGLE-USE ASSEMBLY PRODUCTS

7 SINGLE-USE ASSEMBLIES MARKET, BY SOLUTION

7.1 INTRODUCTION
7.2 STANDARD SOLUTIONS
- 7.2.1 GROWING FOCUS ON CAPITAL COST AND OPERATIONAL FLEXIBILITY TO DRIVE MARKET
7.3 CUSTOMIZED SOLUTIONS
- 7.3.1 NEED FOR ENHANCED PROCESS EFFICIENCY IN BIOPHARMACEUTICAL MANUFACTURING TO PROMOTE GROWTH

8 SINGLE-USE ASSEMBLIES MARKET, BY MODALITY

8.1 INTRODUCTION
8.2 MONOCLONAL ANTIBODIES
- 8.2.1 INCREASING POPULARITY OF TARGETED THERAPY TO PROMOTE GROWTH
8.3 VACCINES
- 8.3.1 ONGOING NEED TO ADDRESS GLOBAL HEALTH CHALLENGES TO AUGMENT GROWTH
8.4 THERAPEUTIC PROTEINS & PEPTIDES
- 8.4.1 GROWING SHIFT TOWARD BIOLOGIC TREATMENTS AND PERSONALIZED MEDICINES TO BOOST MARKET
8.5 CELL & GENE THERAPIES
- 8.5.1 RISING R&D INITIATIVES AND COLLABORATIONS AMONG KEY PLAYERS TO FACILITATE GROWTH

9 SINGLE-USE ASSEMBLIES MARKET, BY APPLICATION

9.1 INTRODUCTION
9.2 FILTRATION & PURIFICATION APPLICATIONS
- 9.2.1 INCREASING FOCUS ON MANUFACTURING AFFORDABLE BIOPHARMACEUTICALS TO SPUR GROWTH
9.3 ASEPTIC TRANSFER
- 9.3.1 GROWING DEMAND FOR BIOLOGICS AND CELL & GENE THERAPIES TO FUEL MARKET
9.4 STORAGE APPLICATIONS
- 9.4.1 NEED FOR FLEXIBLE AND SCALABLE STORAGE OPTIONS TO CONTRIBUTE TO GROWTH
9.5 SAMPLING APPLICATIONS
- 9.5.1 INCREASING COMPLEXITY IN BIOLOGICS MANUFACTURING TO ENCOURAGE GROWTH
9.6 CELL CULTURE
- 9.6.1 GROWING INVESTMENTS IN SINGLE-USE BIOPROCESSING INFRASTRUCTURE TO BOOST MARKET
9.7 FORMULATION & FILL-FINISH APPLICATIONS
- 9.7.1 GROWING TREND OF OUTSOURCING TO PROPEL MARKET
9.8 MIXING APPLICATIONS
- 9.8.1 PRE-STERILIZED DESIGN AND AUTOMATED DESIGNS TO ACCELERATE GROWTH

10 SINGLE-USE ASSEMBLIES MARKET, BY END USER

10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- 10.2.1 RISING PRODUCTION OF BIOLOGICS AND BIOSIMILARS TO SUSTAIN GROWTH
10.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
- 10.3.1 GROWING PREFERENCE FOR OUTSOURCING RESEARCH AND MANUFACTURING ACTIVITIES TO STIMULATE GROWTH
10.4 ACADEMIC & RESEARCH INSTITUTES
- 10.4.1 INCREASING COLLABORATIONS BETWEEN PHARMACEUTICAL & BIOPHARMACEUTICAL MANUFACTURERS AND RESEARCH INSTITUTES TO FUEL MARKET

11 SINGLE-USE ASSEMBLIES MARKET, BY REGION

11.1 INTRODUCTION
11.2 NORTH AMERICA
- 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 11.2.2 US
  - 11.2.2.1 Highly advanced infrastructure and private funding to facilitate growth
- 11.2.3 CANADA
  - 11.2.3.1 Increasing government support for biologics manufacturing to expedite growth
11.3 EUROPE
- 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 11.3.2 GERMANY
  - 11.3.2.1 High government R&D investment and facility expansions by key players to aid growth
- 11.3.3 UK
  - 11.3.3.1 Increased production of novel therapies, devices, and diagnostics to stimulate growth
- 11.3.4 FRANCE
  - 11.3.4.1 Rising number of research collaborations and healthcare investments to sustain growth
- 11.3.5 ITALY
  - 11.3.5.1 Increasing investment in advanced biomanufacturing facilities to spur growth
- 11.3.6 SPAIN
  - 11.3.6.1 Increasing development of targeted therapies to contribute to growth
- 11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
- 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 11.4.2 CHINA
  - 11.4.2.1 Low manufacturing costs and high investments in biotechnology sector to encourage growth
- 11.4.3 SOUTH KOREA
  - 11.4.3.1 Evolving pharmaceutical manufacturing market to accelerate growth
- 11.4.4 JAPAN
  - 11.4.4.1 Robust regulatory framework and technological expertise to favor growth
- 11.4.5 INDIA
  - 11.4.5.1 Low labor cost and availability of skilled professionals to propel market
- 11.4.6 AUSTRALIA
  - 11.4.6.1 Increased investments in clinical trials to augment growth
- 11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
- 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 11.5.2 BRAZIL
  - 11.5.2.1 Increasing adoption of cell & gene therapies to promote growth
- 11.5.3 MEXICO
  - 11.5.3.1 Growing foreign direct investments to boost market
- 11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST
- 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
- 11.6.2 GCC COUNTRIES
  - 11.6.2.1 Saudi Arabia
    - 11.6.2.1.1 Growing investments in healthcare infrastructure and research to fuel market
  - 11.6.2.2 UAE
    - 11.6.2.2.1 Rising focus on developing life science products to support growth
  - 11.6.2.3 Rest of GCC countries
- 11.6.3 REST OF MIDDLE EAST
11.7 AFRICA
- 11.7.1 GROWING DEMAND FOR CRITICAL DRUGS TO DRIVE MARKET
- 11.7.2 MACROECONOMIC OUTLOOK FOR AFRICA

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SINGLE-USE ASSEMBLIES MARKET
12.3 REVENUE ANALYSIS, 2019-2023
12.4 MARKET SHARE ANALYSIS, 2023
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 12.5.1 STARS
- 12.5.2 EMERGING LEADERS
- 12.5.3 PERVASIVE PLAYERS
- 12.5.4 PARTICIPANTS
- 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 12.5.5.1 Company footprint
  - 12.5.5.2 Region footprint
  - 12.5.5.3 Product footprint
  - 12.5.5.4 Solution footprint
  - 12.5.5.5 Application footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 12.6.1 PROGRESSIVE COMPANIES
- 12.6.2 RESPONSIVE COMPANIES
- 12.6.3 DYNAMIC COMPANIES
- 12.6.4 STARTING BLOCKS
- 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION AND FINANCIAL METRICS
- 12.7.1 FINANCIAL METRICS
- 12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
- 12.9.1 PRODUCT LAUNCHES
- 12.9.2 DEALS
- 12.9.3 EXPANSIONS

13 COMPANY PROFILES

13.1 KEY PLAYERS
- 13.1.1 THERMO FISHER SCIENTIFIC INC.
  - 13.1.1.1 Business overview
  - 13.1.1.2 Products offered
  - 13.1.1.3 Recent developments
    - 13.1.1.3.1 Product launches
    - 13.1.1.3.2 Deals
    - 13.1.1.3.3 Expansions
  - 13.1.1.4 MnM view
    - 13.1.1.4.1 Key strengths
    - 13.1.1.4.2 Strategic choices
    - 13.1.1.4.3 Weaknesses and competitive threats
- 13.1.2 SARTORIUS AG
  - 13.1.2.1 Business overview
  - 13.1.2.2 Products offered
  - 13.1.2.3 Recent developments
    - 13.1.2.3.1 Deals
    - 13.1.2.3.2 Expansions
  - 13.1.2.4 MnM view
    - 13.1.2.4.1 Key strengths
    - 13.1.2.4.2 Strategic choices
    - 13.1.2.4.3 Weaknesses and competitive threats
- 13.1.3 MERCK KGAA
  - 13.1.3.1 Business overview
  - 13.1.3.2 Products offered
  - 13.1.3.3 Recent developments
    - 13.1.3.3.1 Product launches
    - 13.1.3.3.2 Deals
    - 13.1.3.3.3 Expansions
  - 13.1.3.4 MnM view
    - 13.1.3.4.1 Key strengths
    - 13.1.3.4.2 Strategic choices
    - 13.1.3.4.3 Weaknesses and competitive threats
- 13.1.4 DANAHER CORPORATION
  - 13.1.4.1 Business overview
  - 13.1.4.2 Products offered
  - 13.1.4.3 Recent developments
    - 13.1.4.3.1 Product launches
    - 13.1.4.3.2 Deals
    - 13.1.4.3.3 Expansions
  - 13.1.4.4 MnM view
    - 13.1.4.4.1 Key strengths
    - 13.1.4.4.2 Strategic choices
    - 13.1.4.4.3 Weaknesses and competitive threats
- 13.1.5 AVANTOR, INC.
  - 13.1.5.1 Business overview
  - 13.1.5.2 Products offered
  - 13.1.5.3 Recent developments
    - 13.1.5.3.1 Deals
    - 13.1.5.3.2 Expansions
- 13.1.6 PARKER HANNIFIN CORPORATION
  - 13.1.6.1 Business overview
  - 13.1.6.2 Products offered
  - 13.1.6.3 Recent developments
    - 13.1.6.3.1 Expansions
- 13.1.7 SAINT-GOBAIN
  - 13.1.7.1 Business overview
  - 13.1.7.2 Products offered
  - 13.1.7.3 Recent developments
    - 13.1.7.3.1 Product launches
    - 13.1.7.3.2 Deals
    - 13.1.7.3.3 Expansions
- 13.1.8 REPLIGEN CORPORATION
  - 13.1.8.1 Business overview
  - 13.1.8.2 Products offered
  - 13.1.8.3 Recent developments
    - 13.1.8.3.1 Deals
    - 13.1.8.3.2 Expansions
- 13.1.9 CORNING INCORPORATED
  - 13.1.9.1 Business overview
  - 13.1.9.2 Products offered
- 13.1.10 ENTEGRIS
  - 13.1.10.1 Business overview
  - 13.1.10.2 Products offered
  - 13.1.10.3 Recent developments
    - 13.1.10.3.1 Expansions
- 13.1.11 LONZA
  - 13.1.11.1 Business overview
  - 13.1.11.2 Products offered
- 13.1.12 ZACROS CORPORATION
  - 13.1.12.1 Business overview
  - 13.1.12.2 Products offered
  - 13.1.12.3 Recent developments
    - 13.1.12.3.1 Expansions
- 13.1.13 W. L. GORE & ASSOCIATES, INC.
  - 13.1.13.1 Business overview
  - 13.1.13.2 Products offered
13.2 OTHER PLAYERS
- 13.2.1 NEWAGE INDUSTRIES
- 13.2.2 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
- 13.2.3 COBETTER
- 13.2.4 ANTYLIA SCIENTIFIC
- 13.2.5 NUPORE FILTRATION SYSTEMS
- 13.2.6 INTELLITECH, INC.
- 13.2.7 MEISSNER FILTRATION PRODUCTS, INC.
- 13.2.8 SANISURE
- 13.2.9 SENTINEL PROCESS SYSTEMS INC.
- 13.2.10 FLUID FLOW PRODUCTS, INC.
- 13.2.11 DOVER CORPORATION
- 13.2.12 KEOFITT A/S
- 13.2.13 CELLEXUS
- 13.2.14 FOXX LIFE SCIENCES
- 13.2.15 TSE INDUSTRIES, INC.

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS